Optiray 160 and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Optiray 160 (ioversol), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Lisinopril, and have Computerised tomogram abdomen.

The phase IV clinical study analyzes which people have Itching when taking Optiray 160. It is created by eHealthMe based on reports of 535 people who have side effects when taking Optiray 160 from the FDA, and is updated regularly.

What is Optiray 160?

Optiray 160 has active ingredients of ioversol. eHealthMe is studying from 536 Optiray 160 users. Check the latest studies of Optiray 160.

What is Itching?

Itching is found to be associated with 3,211 drugs and 4,538 conditions by eHealthMe. Check the latest studies of Itching.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

535 people reported to have side effects when taking Optiray 160.
Among them, 40 people (7.48%) have Itching.

Among these 40 people:

How long have people been on Optiray 160 when they have Itching? *

What is the gender of people who have Itching when taking Optiray 160? *

female: 62.16 %
male: 37.84 %

What is the age of people who have Itching when taking Optiray 160? *

What are other drugs people take besides Optiray 160? *

What are other side effects people have besides Itching? *

Rashes (redness): 21 people, 52.50%
Urticaria (rash of round, red welts on the skin that itch intensely): 11 people, 27.50%
Throat Irritation: 7 people, 17.50%
Chest Pain: 6 people, 15.00%
Sneezing: 4 people, 10.00%
Hypotension (abnormally low blood pressure): 4 people, 10.00%
Hyperhidrosis (abnormally increased sweating): 3 people, 7.50%
Dyspnea (difficult or laboured breathing): 3 people, 7.50%
Eye Swelling: 2 people, 5.00%
Dizziness: 2 people, 5.00%

What are the existing conditions these people have? *

Computerised Tomogram Abdomen: 2 people, 5.00%
Pain: 1 person, 2.50%
Osteoporosis (bones weak and more likely to break): 1 person, 2.50%
Mediastinal Disorder (disease of mediastinum): 1 person, 2.50%
Incontinence (lack of moderation or self-control): 1 person, 2.50%
High Blood Cholesterol: 1 person, 2.50%
Diabetes: 1 person, 2.50%
Computerised Tomogram Abnormal: 1 person, 2.50%
Cardiac Disorder: 1 person, 2.50%
Blood Pressure Abnormal: 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Optiray 160 and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Optiray 160:

Optiray 160 (536 reports)

Itching treatments and more:

Itching (398,823 reports)

Browse all side effects of Optiray 160:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,211 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,538 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ioversol (the active ingredients of Optiray 160) and Optiray 160 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.